Financhill
Sell
28

OGEN Quote, Financials, Valuation and Earnings

Last price:
$0.28
Seasonality move :
-21%
Day range:
$0.27 - $0.29
52-week range:
$0.25 - $3.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.16x
P/B ratio:
2.42x
Volume:
906.9K
Avg. volume:
9.7M
1-year change:
-92.16%
Market cap:
$3.6M
Revenue:
--
EPS (TTM):
-$7.07

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Oragenics has 30512.24% upside to fair value with a price target of -- per share.

OGEN vs. S&P 500

  • Over the past 5 trading days, Oragenics has underperformed the S&P 500 by -1.1% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Oragenics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Oragenics has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Oragenics reported revenues of --.

Earnings Growth

  • Oragenics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Oragenics reported earnings per share of -$0.38.
Enterprise value:
2.6M
EV / Invested capital:
--
Price / LTM sales:
1.16x
EV / EBIT:
--
EV / Revenue:
2.35x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.33x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$14.4M -$10.4M -$20M -$2.1M -$2.4M
EBITDA -$14.3M -$10.1M -$19.9M -$2M -$2.5M
Diluted EPS -$7.02 -$4.67 -$7.07 -$0.85 -$0.38
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $10.5M $30.5M $14.5M $7.8M $4.1M
Total Assets $11.3M $31.1M $15M $7.9M $5.2M
Current Liabilities $1.1M $2.2M $1.5M $1.4M $2.1M
Total Liabilities $1.6M $2.5M $1.7M $1.4M $2.1M
Total Equity $9.6M $28.5M $13.3M $6.5M $3.1M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$15.3M -$8.6M -$7.7M -$1.5M -$2M
Cash From Investing -$131.8K -- -- $63.7K --
Cash From Financing -$585.8K $376.5K $6.1M $732.1K $3.8M
Free Cash Flow -$15.4M -$8.6M -$7.7M -$1.5M -$2M
OGEN
Sector
Market Cap
$3.6M
$43.3M
Price % of 52-Week High
7.56%
47.98%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
-92.16%
-36.92%
Beta (5-Year)
0.380
0.753
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $0.28
200-day SMA
Sell
Level $0.81
Bollinger Bands (100)
Sell
Level 0.29 - 0.39
Chaikin Money Flow
Sell
Level -1B
20-day SMA
Sell
Level $0.29
Relative Strength Index (RSI14)
Sell
Level 47.51
ADX Line
Buy
Level 32.79
Williams %R
Buy
Level -88.418
50-day SMA
Sell
Level $0.33
MACD (12, 26)
Sell
Level -0.01
25-day Aroon Oscillator
Sell
Level -4
On Balance Volume
Neutral
Level 2B

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Stock Forecast FAQ

In the current month, OGEN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OGEN average analyst price target in the past 3 months is --.

  • Where Will Oragenics Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Oragenics share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Oragenics?

    Analysts are divided on their view about Oragenics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oragenics is a Sell and believe this share price will drop from its current level to --.

  • What Is Oragenics's Price Target?

    The price target for Oragenics over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is OGEN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Oragenics is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of OGEN?

    You can purchase shares of Oragenics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oragenics shares.

  • What Is The Oragenics Share Price Today?

    Oragenics was last trading at $0.28 per share. This represents the most recent stock quote for Oragenics. Yesterday, Oragenics closed at $0.29 per share.

  • How To Buy Oragenics Stock Online?

    In order to purchase Oragenics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 110x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Buy
58
UPST alert for Feb 13

Upstart Holdings [UPST] is up 31.82% over the past day.

Buy
79
CFLT alert for Feb 13

Confluent [CFLT] is up 24.92% over the past day.

Buy
52
BL alert for Feb 13

BlackLine [BL] is down 18.03% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock